Current opinion in urology 2017: Focal therapy of small renal lesions

Brett A. Johnson, Jeffrey A Cadeddu

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Purpose of review With the increasing incidence of small renal masses (SRMs), ablative technologies are becoming more commonly utilized. With any nascent treatment modality, outcomes literature needs to be constantly re-evaluated. The purpose of this review is to revisit the most updated literature regarding the safety and efficacy of ablative treatments of renal lesions. Recent findings Recent literature demonstrates that small renal tumor ablation is safe and effective. Although it does not have the same oncological efficacy of surgical extirpation, local recurrence-free survival has consistently shown to be around 90%. Cryoablation and radiofrequency ablation have longer-term data demonstrating durable responses. Microwave ablation and irreversible electroporation are promising modalities with longer-term data coming. Complication rates and procedural morbidity of ablation are consistently lower than for partial nephrectomy. Summary Image-guided focal ablation is a valuable tool in the management of SRMs. Although it does not have the same efficacy of surgical extirpation, with the ability to perform repeat procedures and salvage surgery if necessary, oncologic outcomes are comparable to those of upfront surgery. Ultimately, longer-term studies and prospective trials are needed to further elucidate these modalities.

Original languageEnglish (US)
Pages (from-to)166-171
Number of pages6
JournalCurrent Opinion in Urology
Volume28
Issue number2
DOIs
StatePublished - Mar 1 2018

Fingerprint

Urology
Kidney
Cryosurgery
Electroporation
Therapeutics
Microwaves
Nephrectomy
Prospective Studies
Technology
Morbidity
Safety
Recurrence
Incidence
Neoplasms

Keywords

  • cryoablation
  • irreversible electroporation
  • kidney cancer
  • microwave ablation
  • radio-frequency ablation
  • renal cell carcinoma
  • renal mass ablation
  • small renal mass
  • thermal ablation

ASJC Scopus subject areas

  • Urology

Cite this

Current opinion in urology 2017 : Focal therapy of small renal lesions. / Johnson, Brett A.; Cadeddu, Jeffrey A.

In: Current Opinion in Urology, Vol. 28, No. 2, 01.03.2018, p. 166-171.

Research output: Contribution to journalReview article

@article{0abf027cbdb14284ac7164e3e26236e8,
title = "Current opinion in urology 2017: Focal therapy of small renal lesions",
abstract = "Purpose of review With the increasing incidence of small renal masses (SRMs), ablative technologies are becoming more commonly utilized. With any nascent treatment modality, outcomes literature needs to be constantly re-evaluated. The purpose of this review is to revisit the most updated literature regarding the safety and efficacy of ablative treatments of renal lesions. Recent findings Recent literature demonstrates that small renal tumor ablation is safe and effective. Although it does not have the same oncological efficacy of surgical extirpation, local recurrence-free survival has consistently shown to be around 90{\%}. Cryoablation and radiofrequency ablation have longer-term data demonstrating durable responses. Microwave ablation and irreversible electroporation are promising modalities with longer-term data coming. Complication rates and procedural morbidity of ablation are consistently lower than for partial nephrectomy. Summary Image-guided focal ablation is a valuable tool in the management of SRMs. Although it does not have the same efficacy of surgical extirpation, with the ability to perform repeat procedures and salvage surgery if necessary, oncologic outcomes are comparable to those of upfront surgery. Ultimately, longer-term studies and prospective trials are needed to further elucidate these modalities.",
keywords = "cryoablation, irreversible electroporation, kidney cancer, microwave ablation, radio-frequency ablation, renal cell carcinoma, renal mass ablation, small renal mass, thermal ablation",
author = "Johnson, {Brett A.} and Cadeddu, {Jeffrey A}",
year = "2018",
month = "3",
day = "1",
doi = "10.1097/MOU.0000000000000475",
language = "English (US)",
volume = "28",
pages = "166--171",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Current opinion in urology 2017

T2 - Focal therapy of small renal lesions

AU - Johnson, Brett A.

AU - Cadeddu, Jeffrey A

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose of review With the increasing incidence of small renal masses (SRMs), ablative technologies are becoming more commonly utilized. With any nascent treatment modality, outcomes literature needs to be constantly re-evaluated. The purpose of this review is to revisit the most updated literature regarding the safety and efficacy of ablative treatments of renal lesions. Recent findings Recent literature demonstrates that small renal tumor ablation is safe and effective. Although it does not have the same oncological efficacy of surgical extirpation, local recurrence-free survival has consistently shown to be around 90%. Cryoablation and radiofrequency ablation have longer-term data demonstrating durable responses. Microwave ablation and irreversible electroporation are promising modalities with longer-term data coming. Complication rates and procedural morbidity of ablation are consistently lower than for partial nephrectomy. Summary Image-guided focal ablation is a valuable tool in the management of SRMs. Although it does not have the same efficacy of surgical extirpation, with the ability to perform repeat procedures and salvage surgery if necessary, oncologic outcomes are comparable to those of upfront surgery. Ultimately, longer-term studies and prospective trials are needed to further elucidate these modalities.

AB - Purpose of review With the increasing incidence of small renal masses (SRMs), ablative technologies are becoming more commonly utilized. With any nascent treatment modality, outcomes literature needs to be constantly re-evaluated. The purpose of this review is to revisit the most updated literature regarding the safety and efficacy of ablative treatments of renal lesions. Recent findings Recent literature demonstrates that small renal tumor ablation is safe and effective. Although it does not have the same oncological efficacy of surgical extirpation, local recurrence-free survival has consistently shown to be around 90%. Cryoablation and radiofrequency ablation have longer-term data demonstrating durable responses. Microwave ablation and irreversible electroporation are promising modalities with longer-term data coming. Complication rates and procedural morbidity of ablation are consistently lower than for partial nephrectomy. Summary Image-guided focal ablation is a valuable tool in the management of SRMs. Although it does not have the same efficacy of surgical extirpation, with the ability to perform repeat procedures and salvage surgery if necessary, oncologic outcomes are comparable to those of upfront surgery. Ultimately, longer-term studies and prospective trials are needed to further elucidate these modalities.

KW - cryoablation

KW - irreversible electroporation

KW - kidney cancer

KW - microwave ablation

KW - radio-frequency ablation

KW - renal cell carcinoma

KW - renal mass ablation

KW - small renal mass

KW - thermal ablation

UR - http://www.scopus.com/inward/record.url?scp=85042431066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042431066&partnerID=8YFLogxK

U2 - 10.1097/MOU.0000000000000475

DO - 10.1097/MOU.0000000000000475

M3 - Review article

C2 - 29303914

AN - SCOPUS:85042431066

VL - 28

SP - 166

EP - 171

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 2

ER -